A nervous Dassault is spending $2bn on AI, in the division dragging it down

Dassault Systèmes is acquiring ArisGlobal for about $2 billion to enhance its AI capabilities in drug safety and regulatory software, aiming to integrate real-world patient data with virtual models. This move targets the growing market for AI-driven compliance software in life sciences and supports Dassault's virtual twin technology.